No Prescription |
 |
 | ||
|
AZORAN Imuran |
|
| ||
No Prescription » Prescription Drugs 2 » AZORAN Imuran Azathioprine is used with other medications to prevent rejection of a kidney transplant. It works by weakening your body's defense system (immune system) to help your body accept the new kidney as if it were your own. This medication belongs to a class of drugs known as immunosuppressants.Azathioprine is also used to treat patients with severe rheumatoid arthritis who have not responded to other medications (e.g. nonsteroidal anti-inflammatory drugs/NSAIDs such as ibuprofen). Rheumatoid arthritis is thought to be caused by the immune system attacking the joints. Early treatment of rheumatoid arthritis with more aggressive therapy such as azathioprine helps to reduce further joint damage and to preserve joint function.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication may also be used to prevent rejection of other transplanted organs to treat a certain type of bowel condition (Crohn's disease) that is not responsive to usual treatment and to treat other immune system problems (autoimmune diseases) as determined by your doctor.How to use Azathioprine OralTake this medication by mouth usually once or twice daily as directed by your doctor. Azathioprine should be taken with food to reduce stomach upset. Dosage is based on your medical condition weight and response to therapy. For the treatment of rheumatoid arthritis the manufacturer recommends that you do not take more than 2.5 milligrams per kilogram per day.Do not increase your dose or take this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased. Also do not stop taking this medication without your doctor's approval.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day.For arthritis it may take up to 2 months of continued use to notice relief of symptoms. Inform your doctor if your condition does not improve after 3 months of treatment.Since this drug can be absorbed through the skin women who are pregnant or who may become pregnant should not handle or break the tablets of this medication. Buy AZORAN Imuran and other Prescription Drugs 2 products online at Medstore. 760
About AZORAN Imuran: Product Type: Prescription Drugs 2 AZORAN ( Imuran Imuzat Generic Azathioprine ) AZORAN (Imuran Imuzat Generic Azathioprine) Imuran Imuzat Generic Azathioprine 50mg Tabs 100 Tablets Imuran Imuzat Generic Azathioprine AZORAN
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
